TBI Bioscan Newsletter - November 2009
Superstar scientists highlight TBI’s October breakfast session
Superstar scientists highlight TBI’s October breakfast session
It is hoped that one day, regenerative medicine will help to produce extended healthy longevity. All of the most impressive demonstrations of regenerative medicine, since the beginning of the century, have used varying forms of stem cells, embryonic, adult and most recently induced pluripotent stem cells to trigger healing within the patient. A great deal of press attention, for example, has been given to success in alleviating life-threatening heart conditions.
Canada’s Gairdner Awards: Fifty years of making science matter
Canada’s Gairdner Awards: Fifty years of making science matter
On October 28th-30th, the world’s most celebrated scientific superstars gathered in Toronto to mark the 50th anniversary of Canada’s largest celebration of science: The Canada Gairdner Awards.
TBI News
TBI Mentorship Program Update
On November 5, The Biotechnology Initiative (TBI) held its first “Meet and Greet” event for participants in the TBI Mentorship program.
Moving the Industry forward
By: Grant Tipler - Grant Tipler is the head of the Life Sciences & Health Services team of the Knowledge Based Industries group at RBC Royal Bank and past President of TBI
Let's face it - the last year has been a period of retrenchment for the life sciences industry. Whether you consider this to be a positive or negative turn of events depends on which side of the fence you're on. On one side, for example, a number of companies without access to significant capital have had to lay off employees to preserve their programs and to protect their intellectual property. On the other hand, some weaker companies have merged with stronger partners to create new organizations that offer a greater depth and breadth of programs to their customers.
Members Take Note: Toronto District School Board, Beakers for Teachers, & Shanghai Conference 2009
The Toronto District School Board is looking for industry partners to sit on an advisory board for a new Biotechnology curriculum.
Beakers for Teachers, do you have equipment that you can't use?
The Biotechnology Initiative is an Event Partner for the Shanghai Conference 2009.
Mentor. Partner. Learn. Grow.
TBI recently launched its mentorship program to help develop business and science professionals and build a stronger network of expertise within Ontario. The program offers individuals the opportunity to connect with other professionals with similar interests or backgrounds to promote development, addressing the need for human capital in the biotech industry.
Agricultural diversity can provide many solutions to energy needs
National Biotechnology Week is a celebration of life sciences’ contributions to society, showing how new advances are affecting our every day lives. From health to the bioeconomy to the environment, biotechnology and life sciences developments have clearly addressed many of society’s needs. The Biotechnology Initiative (TBI) believes that knowledge is a key driver to technology use, and that education is key to informed decisions about policy.
TBI Member News
Spotlight shines on Toronto during first ever "National Canadian Science Policy Conference"
The first ever National Canadian Science Policy Conference, held October 28-30, brought notable names from the biotechnology and life sciences industry, government and academia to Toronto to discuss the future of Canada’s science policy infrastructure. During the three-day-event, approximately 60 speakers, including several prominent figures addressed more than 420 delegates on a variety of current related issues.
Immunovaccine Inc. is partnering and collaborating with organizations to make better vaccines
Immunovaccine Inc. is partnering and collaborating with organizations to make better vaccines. On November 10th Immunovaccine announced the signing of a new collaborative agreement with the National Cancer Institute (NCI) in Maryland, USA to assist in development of cancer vaccines by formulating NCI’s antigens in the DepoVax™ vaccine enhancement technology.
Immunovaccine Inc. (IMV) starts trading on TSX-V
Immunovaccine Inc. is pleased to announce it will begin trading on the TSX-Venture Exchange as of October 5, 2009. Immunovaccine Inc. will trade as a Tier 1 issuer under the ticker symbol "IMV”. The company successfully closed a concurrent round of financing to support the Phase 1 clinical for DPX-0907, a therapeutic breast ovarian and prostate cancer vaccine, and intends to start the trial in Q1 2010.
Immunovaccine Inc. is continuing to develop breakthrough technologies to make vaccines better. The company continues to strengthen its vaccine pipeline through licensing and strategic partnering.
Immunovaccine will be presenting at BioContact in Quebec City, BioPartnering Europe in London, the Life Sciences and Health Care Venture Summit in New York, Bio Investor Forum in San Francisco and Bio Europe in Vienna.
Amorfix Appoints Dr. Philippe Couillard to it's Board of Directors
TORONTO, ON - Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, announced today that Philippe Couillard, MD, former Minister of Health and Social Services for Quebec, has been appointed to its Board of Directors.
Click Here for more Member News
Upcoming TBI Events
A Toast to TBI
TBI's Pub Night at the Duke of York will be a casual opportunity to meet and network with people from all across the biotech industry.
2010 TBI Gala "A Celebration of Success"
The Biotechnology Initiative (TBI) invites you to join us in a 'Celebration of Success'.
On Tuesday, February 23, 2010, Lorne Meikle, President of TBI, will host our annual President’s Awards Gala at the Four Season’s Hotel in Toronto. This is a "must attend" function for all of us who support biotechnology in Canada. A first class ambiance will provide a background for you and your colleagues to come together in recognition of individuals who have contributed so much to this great sector.
Industry Events
ABIC 2010 conference
The ABIC 2010 website was launched on 22 September 2009. Registration for the conference is open, with early bird rates in effect until July 15, 2010.
Click here to view more events
Feature Career Opportunities
Preclinical CRO Business Development Director
Toronto-based
Staff Writer
Aurora, ON
Senior Formulation Scientist
Markham
Click Here for a full list of employment opportunities available through TBI's careers page
Join the #1 Life Sciences Network in Ontario
The Biotechnology Initiative represents and promotes life sciences technologies and encourages their commercial success in Ontario through networking events, government advocacy, stakeholder engagement, mentoring and education and promotion of Ontario’s world-class science and industry.
Click here for more member benefits and to join the #1 Life Sciences Network in Ontario
CONTACT US
To include your announcement on TBI’s web site or upcoming Bioscan newsletter, send your release to news@ontbi.org
Please forward all releases as word documents.
